Ayla Annac

CEO/President @ InvivoSciences Inc. | TedX speaker, Biotech, Finance, Leadership, Technology Entrepreneur, Titan 100 CEO 2024

View articles by Ayla Annac

IVS receives NIH SBIR Fast Track award for the development of its predictive drug safety assessment platform. Release Date: September 20, 2018.
Ayla

IVS receives NIH SBIR Fast Track award for…

September 20, 2018

23 likes10 comments

Critical Developments in Cardio-Oncology- at SOT 2017

Critical Developments in Cardio-Oncology- at…

March 10, 2017

4 likes

A journey of a biotech entrepreneur to heal heart disease and contribute to develop safe and effective drugs

A journey of a biotech entrepreneur to heal…

July 30, 2016

13 likes2 comments

Hamamatsu Photonics & InvivoSciences, are in strategic collaboration.

Hamamatsu Photonics & InvivoSciences, are in…

June 13, 2015

17 likes5 comments

InvivoSciences is selected to exhibit in Innovation Zone at the BIO 2015

InvivoSciences is selected to exhibit in…

May 13, 2015

19 likes10 comments

Selected as one of the most promising companies

Selected as one of the most promising…

May 13, 2014

13 likes3 comments

Vote for InvivoSciences at BIO Buzz

Vote for InvivoSciences at BIO Buzz

April 16, 2014

Please Vote for IVS for the Buzz of Bio!

Please Vote for IVS for the Buzz of Bio!

April 14, 2014

1 like